Abstract:Copper-based nanomaterials (Cu-based NMs) with favorable biocompatibility and unique properties have attracted the attention of many biomedical researchers. Cu-based NMs are one of the most widely studied materials in cancer treatment. In recent years, great progress has been made in the field of biomedicine, especially in the treatment and diagnosis of tumors. This review begins with the classification of Cu-based NMs and the recent synthetic strategies of Cu-based NMs. Then, according to the abundant and special properties of Cu-based NMs, their application in biomedicine is summarized in detail. For biomedical imaging, such as photoacoustic imaging, positron emission tomography imaging, and multimodal imaging based on Cu-based NMs are summarized, as well as strategies to improve the diagnostic effectiveness. Moreover, a series of unique structures and functions as well as the underlying property activity relationship of Cu-based NMs were shown to highlight their promising therapeutic performance. Cu-based NMs have been widely used in monotherapies, such as photothermal therapy (PTT) and chemodynamic therapy (CDT). Moreover, the sophisticated design in composition, structure, and surface fabrication of Cu-based NMs can endow these NMs with more modalities in cancer diagnosis and therapy. To further improve the efficiency of cancer treatment, combined therapy based on Cu-based NMs was introduced in detail. Finally, the challenges, critical factors, and future prospects for the clinical translation of Cu-based NMs as multifunctional theranostic agents were also considered and discussed. The aim of this review is to provide a better understanding and key consideration for the rational design of this increasingly important new paradigm of Cu-based NMs as theranostic agents. This article is categorized under: Therapeutic Approaches and Drug Discovery > Nanomedicine for Oncologic Disease Diagnostic Tools > In Vivo Nanodiagnostics and Imaging.

The Copper Age in Cancer Treatment: from Copper Metabolism to Cuproptosis

Cuproptosis: Harnessing Transition Metal for Cancer Therapy

Recent Advances in the Biomedical Applications of Copper Nanomaterial‐Mediated Cuproptosis

Copper-based Nanomaterials for Cancer Theranostics

Copper-Based Nanomaterials: A Rising Star in Cancer Therapy

Dissecting copper biology and cancer treatment: ‘Activating Cuproptosis or suppressing Cuproplasia’

Copper Coordination‐Based Nanomedicine for Tumor Theranostics

Recent Advances in Cancer Therapeutic Copper-Based Nanomaterials for Antitumor Therapy

Biocompatible Copper-Based Nanocomposites for Combined Cancer Therapy

Copper Coordination-Based Nanomedicine for Tumor Theranostics

Multifaceted Roles of Copper ions in Anticancer Nanomedicine

Recent Advances in Copper Homeostasis-Involved Tumor Theranostics

Cope with copper: From copper linked mechanisms to copper-based clinical cancer therapies

Copper homeostasis and cuproptosis in tumor pathogenesis and therapeutic strategies

Copper As the Target for Anticancer Nanomedicine

Cu-related Agents for Cancer Therapies

Copper-Based Nanomedicines for Cuproptosis-Mediated Effective Cancer Treatment

Copper-induced tumor cell death mechanisms and antitumor theragnostic applications of copper complexes

Cuproptosis Nanomedicine: Clinical Challenges and Opportunities for Anti-Tumor Therapy

Copper and Copper Complexes in Tumor Therapy

Harnessing nanomaterials for copper-induced cell death